We are live on ! Find out more
FFTY icon

CapForce IBD 50 ETF

70 hedge funds and large institutions have $92.9M invested in CapForce IBD 50 ETF in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 21 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

519% more call options, than puts

Call options by funds: $1.98M | Put options by funds: $320K

45% more capital invested

Capital invested by funds: $64M → $92.9M (+$28.9M)

43% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 7

9.48% more ownership

Funds ownership: 26.44%35.92% (+9.5%)

3% more funds holding

Funds holding: 6870 (+2)

0% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 21

Holders
70
Holders Change
+2
Holders Change %
+2.94%
% of All Funds
1.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
21
Reduced
21
Closed
7
Calls
$1.98M
Puts
$320K
Net Calls
+$1.66M
Net Calls Change
+$1.61M
Name Holding Trade Value Shares
Change
Change in
Stake
Group One Trading
76
Group One Trading
Illinois
-$4.67K -100 Closed
BFEC
77
Benjamin F. Edwards & Company
Missouri
+$467 +10 New

FFTY Hedge Fund Activity: Q3 2021 in Review

70 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in CapForce IBD 50 ETF (FFTY) for Q3 2021, worth a combined $92.9M — up 45% from $64M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new FFTY positions and 7 closed out — a net gain of 3 holders — while 21 added to existing stakes and 21 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $14.1M. The largest seller was Tower Research Capital (TRC), cutting an estimated $1.85M.

  • 70 institutional investors held CapForce IBD 50 ETF (FFTY) as of Q3 2021, up from 68 in Q2 2021.
  • Funds reported $92.9M of CapForce IBD 50 ETF stock for Q3 2021, up 45% quarter-over-quarter.
  • 10 funds opened new CapForce IBD 50 ETF positions in Q3 2021 and 7 closed out, a net change of +3 holders.
  • The largest CapForce IBD 50 ETF buyer in Q3 2021 was Susquehanna International Group, an estimated $14.1M added.
  • The largest CapForce IBD 50 ETF seller in Q3 2021 was Tower Research Capital (TRC), an estimated $1.85M sold.

Based on aggregated 13F filings for Q3 2021.